Schizophrenia and Schizoaffective Disorders (Pediatric) Clinical Trials

A listing of Schizophrenia and Schizoaffective Disorders (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 153 clinical trials
Featured trial
Schizophrenia in Adolescents

Schizophrenia in Adolescents

  • 266 views
  • 08 Nov, 2020
  • 1 location
Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

To evaluate the long-term safety and tolerability of pimavanserin after 52 weeks of adjunctive treatment in subjects with schizophrenia

abilify
aripiprazole
cariprazine
brexpiprazole
paliperidone
  • 380 views
  • 25 Feb, 2022
  • 52 locations
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia

To evaluate the efficacy and safety of adjunctive pimavanserin compared with adjunctive placebo in the treatment of negative symptoms of schizophrenia

abilify
aripiprazole
cariprazine
paliperidone
asenapine
  • 20 views
  • 28 Oct, 2021
  • 86 locations
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia

This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786, as compared with placebo, for the treatment of negative symptoms of schizophrenia.

typical antipsychotic
antipsychotics
psychiatric disorder
  • 703 views
  • 25 Jul, 2022
  • 46 locations
A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia

This is a clinical trial to determine the long-term safety and tolerability of an investigational drug in people with schizophrenia. Participants in the study will receive the drug being studied. This study is accepting male and female participants between 13 and 65 years old who have been diagnosed with schizophrenia …

  • 128 views
  • 29 Jul, 2022
  • 50 locations
Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

The purpose of this study is to evaluate the efficacy and safety of MK-8189 at a range of doses (8 mg, 16 mg, and 24 mg once daily) in adult participants who have an acute episode of schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-5) …

risperidone
  • 4 views
  • 08 Aug, 2022
  • 53 locations
A Clinical Trial to Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia

A clinical trial to study the efficacy and safety of an investigational drug in acutely psychotic people with schizophrenia. Participants in the study will either receive the drug being studied or a placebo. This study is accepting male and female participants between 13 years old -65 years old who have …

hallucinations
psychosis
delusions
psychotic symptoms
  • 195 views
  • 10 Aug, 2022
  • 45 locations
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia

A clinical trial to study the efficacy and safety of an investigational drug in acutely psychotic people with schizophrenia. Participants in the study will either receive the drug being studied or a placebo. This study is accepting male and female participants between 18 -65 years old who have been diagnosed …

hallucinations
psychosis
delusions
psychotic symptoms
  • 155 views
  • 08 Aug, 2022
  • 55 locations
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations

In the current study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in improving executive function across neuropsychiatric populations known to have deficits in this cognitive domain.

substance use disorder
substance use
bipolar disorder
traumatic brain injury
attention deficit disorder
  • 1341 views
  • 28 Feb, 2022
  • 1 location
Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia

Plasma half-life has routinely been used to establish the dosing schedule of antipsychotics; for example, it is recommended that agents with a short plasma half-life be administered multiple times per day. However, to date, several randomized controlled trials (RCTs) have shown no differences in clinical outcomes between once- and twice-daily …

schizophrenia
clozapine
antipsychotics
schizoaffective disorder
  • 141 views
  • 23 Feb, 2022
  • 1 location